AEON Biopharma, Inc.
AEONNYSEAMERICANHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $12.28M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.18$1.45
- Volume (live)
- -
- Avg. volume (3M)
- 12.89M
AEON Biopharma (AEON) Stock Price & Financial Analysis
AEON Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.23 - $0.25 |
|---|---|
| 52-Week High | $1.45 |
| 52-Week Low | $0.18 |
| Open | $0.24 |
| Volume (last close) | 240.50K |
| Average Volume (3M) | 12.89M |
| 50-Day MA | $0.26 |
|---|---|
| 200-Day MA | $0.73 |
| 1-Year Change | −77.91% |
| Market Cap | 12.28M |
|---|---|
| Shares Outstanding | 50.53M |
| Price to Book (P/B) | -0.80 |
| EV/EBITDA | -0.42 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
AEON Biopharma at a Glance
As of the Oct 16, 2026 close, AEON Biopharma (AEON) has a market capitalization of $12.28M.
As of its latest reported balance sheet, it holds $3.43M in cash and securities against $2.02M of debt, a net cash position of $1.41M.
AEON Biopharma does not currently pay a dividend.
The share price is down 77.9% over the past year. At $0.23 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.18 to $1.45, below its 200-day moving average of $0.73.
Frequently Asked Questions About AEON Biopharma
What is the current stock price for AEON?
As of the Oct 16, 2026 close, AEON stock trades at $0.23. The 52-week range is $0.18–$1.45, with a day range of $0.23–$0.25.
What is the P/E ratio for AEON?
The P/E ratio (Price-to-Earnings) for AEON is shown in the Key Statistics section. This valuation metric helps compare AEON Biopharma, Inc. to industry peers.
Does AEON pay dividends?
AEON Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AEON?
Analyst ratings and recommendations for AEON are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of AEON?
As of the Oct 16, 2026 close, AEON Biopharma's market capitalization is $11.7M, classifying it as a micro-cap company. AEON Biopharma operates in the Healthcare sector within the Biotechnology industry.